Nataliya Agafonova
Vermogen: 185 013 $ op 30-09-2026
Vermogen: 185 013 $ op 30-09-2026
Dr. Nataliya Agafonova is a Chief Medical Officer at Longeveron, Inc. Dr. Agafonova was previously employed as a Senior Medical Director by Bristol Myers Squibb Co. and a Senior Medical Director by Otsuka Pharmaceutical Development & Commercialization, Inc. She received her doctorate degree from Bogomolets National Medical University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-10-2026 | 68.778 ( 2,26% ) | 185 013 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LONGEVERON INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-06-2023 |
| BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Bogomolets National Medical University
Bogomolets National Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau